Chandan Taparia of Motilal Oswal Securities has a buy call on Divi's Laboratories with a target price of Rs 920.

The current market price of Divi's Laboratories is Rs 878.80.

Time period given by the analyst is intraday when Divi's Laboratories price can reach defined target.

Chandan Taparia recommended to keep a stop loss at Rs 860.

Divi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 23,329.38 Crore) operating in Pharmaceuticals and health care sector.

Divi's Laboratories key Products/Revenue Segments include Active Pharma Ingredients which contributed Rs 4,052.57 Crore to Sales Value (99.67 per cent of Total Sales), Scrap which contributed Rs 8.98 Crore to Sales Value (0.22 per cent of Total Sales), Contract Fees which contributed Rs 2.17 Crore to Sales Value (0.05 per cent of Total Sales) and Export Incentives which contributed Rs 2.06 Crore to Sales Value (0.05 per cent of Total Sales)for the year ending 31-Mar-2017.

The company's top management includes Dr.G Suresh Kumar, Dr.Murali K Divi, Dr.Ramesh B V Nimmagadda, Mr.K V K Seshavataram, Mr.Kiran S Divi, Mr.Madhusudana Rao Divi, Mr.N V Ramana, Mr.Nilima Motaparti, Mr.R Ranga Rao, Mr.S Ganapaty.

Company has Price Waterhouse as its auditors.

As on 30-09-2017, the company has a total of 265,468,580 shares outstanding.